ASSOCIATION OF ENOS GENE POLYMORPHISMS AS A RISK FACTOR OF CORONARY IN-STENT RESTENOSIS

Cover Page

Abstract


Background: In recent years more attention is paid to the methods of interventional treatment of coronary artery disease. However, despite the numerous clinical studies the problem of stent restenosis after interventional procedures remains an important one. The studies of the molecular mechanisms of restenosis of coronary arteries and findings for new genetically determined predictors of restenosis after stenting become vital and essential. The NO-synthase influence on the development of endothelial dysfunction is practically assured, but the studies on the NOS genes' polymorphism effect on the incidence rate of in-stent restenosis are isolated and based on a limited number of clinical observations. The determined facts demonstrate the relevance of the conducted study, the results of which formed a new understanding of the role of NO-synthase genes in the predisposition to hyper-proliferative stents in patients with coronary artery disease. Aims: Set association between the eNOS gene polymorphisms and the risk of restenosis in patients with coronary artery disease hospitalized for coronary restenosis.

Materials and methods: We examined 484 patients with the verified diagnosis of the ischemic heart disease who underwent treatment at the unit of atherosclerosis and chronic coronary heart disease of «Cardiology Research Institute». Stenting of coronary arteries was performed in 210 people. The group of a restenosis enrolled 60 patients and the group without restenosis — 150. Genotyping was performed by non-enzymatic technique for isolation of genomic DNA from the venous blood of the surveyed, NOS genes' polymorphisms were detected by polymerase chain reaction (PCR).

Results: The established development of in-stent restenosis was associated with the following eNOS gene polymorphisms: VNTR ― in homozygotes for the minor allele (genotype aa) and heterozygotes (genotype ab); 894G/T ― in heterozygotes (the GT genotype) and homozygotes (TT genotype).

Conclusions: VNTR and 894G/T polymorphisms of eNOS gene are associated with risk for restenosis and can serve as additional markers for risk of restenosis after coronary stenting.


L. M. Ogorodova

Siberian State Medical University

Author for correspondence.
Email: lm-ogorodova@mail.ru
ORCID iD: 0000-0002-2962-1076

Russian Federation

Tomsk

K. Y. Rukin

LLC «Management company «United clinical diagnostic laboratory»

Email: eldc-rk@yandex.ru
ORCID iD: 0000-0002-4894-6909

Russian Federation

Moscow

S. I. Vintizenko

Tomsk National Research Medical Center of the Russian Academy of Sciences

Email: stasv@bk.ru
ORCID iD: 0000-0002-9566-4787

Russian Federation

Tomsk

I. V. Petrova

LLC «Management company «United clinical diagnostic laboratory»

Email: irinavall@mail.ru
ORCID iD: 0000-0001-9034-4226

Russian Federation

Moscow

  1. Березикова Е.Н. Клинико-генетические и нейрогормональные механизмы развития ишемического ремоделирования, апоптоза миокарда и сердечной недостаточности: инновационная стратегия персонализированной диагностики, профилактики и лечения: Дис. … докт. мед. наук. ― Томск; 2014. — 315 с. [Berezikova EN. Kliniko-geneticheskie i neirogumoralnye mekhanizmy ishemicheskogo remodelirovaniya, apoptoza miokarda i serdechnoi nedostatochnosti: innovatsionnaya strategiya personalizirovannoi diagnostiki, profilaktiki i lecheniya. [dissertation] Tomsk; 2014. 315 p. (In Russ).]
  2. Maffia P, Ianaro A, Pisano B, et al. Beneficial effects of caffeic acid phenethyl ester in a rat model of vascular injury. Br J Pharmacol. 2002;136(3):353−360. doi: 10.1038/sj.bjp.0704720.
  3. Березикова Е.Н., Попова А.А., Тепляков А.Т. Генетические предикторы развития эндотелиальной дисфункции у больных ишемической болезнью сердца, осложненной хронической сердечной недостаточностью // Сибирское медицинское обозрение. ― 2010. ― №4 ― С. 26–29. [Berezikova EN, Popova AA, Teplyakov AT. Genetic predictors of endothelial dysfunction development in patients with ischemic heart disease complicated by chronic heart failure. Siberian medical review. 2010;(4):25−28. (In Russ).]
  4. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 Suppl 1):27−32. doi: 10.1161/01.CIR.0000131515.03336.f8.
  5. Yang Z, Ming X. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res. 2006;4(1):53−65. doi: 10.3121/cmr.4.1.53.
  6. Юхно Е.С. Значение дисфункции эндотелия и вариабельности генов-кандидатов для прогноза у больных острым коронарным синдромом без подъема сегмента ST: Дис. … канд. мед. наук. ― Кемерово; 2015. — 193 с. [Yukhno ES. Znachenie disfunktsii endoteliya i variabel’nosti genov-kandidatov dlya prognoza u bolinykh ostrym koronarnym sindromom bez pod»ema segmenta ST. [dissertation] Kemerovo; 2015. 193 p. (In Russ).]
  7. Муслимова Э.Ф. Молекулярно-генетические факторы развития осложнений после стентирования коронарных артерий у больных хронической ИБС: Дис. … канд. мед. наук. ― Томск; 2016. — 236 с. [Muslimova EF. Molekulyarno-geneticheskie faktory razvitiya oslozhnenii posle stentirovaniya koronarnykh arterii u bol’nykh khronicheskoi IBS. [dissertation] Tomsk; 2016. 236 p. (In Russ).]
  8. Приступа Л.Н., Погорелова О.С. Ассоциация аллельных полиморфизмов гена эндотелиальной NO-синтазы с развитием ишемической болезни сердца (литературный обзор) // Журнал клинических и экспериментальных медицинских исследований. ― 2015. ― T.3. ― №3 ― С. 375–386. [Prystupa LN, Pohorielova OS. Assosiation between endothelial nitric oxide synthase gene polimorphisms and risk of coronary artery disease (review). Journal of Clinical and Experimental Medical Research. 2015;3(3):375–386. (In Russ).]

Views

Abstract - 17

PDF (Russian) - 5

Cited-By


PlumX



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies